Royalty Pharma (NasdaqGS:RPRX) recently affirmed its dividend, setting it at $0.22 per Class A ordinary share for the second quarter of 2025, demonstrating its financial stability and commitment to ...

We recently published a list of Jim Cramer Recently Talked About These 15 Stocks. In this article, we are going to take a ...

and Biohaven chief executive Vlad Coric. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostrzewski, CSO at CN Bio, about single organ-on-a-chip technology.

BofA raised the firm’s price target on Royalty Pharma (RPRX) to $42 from $41 and keeps a Buy rating on the shares. The firm, in its preview of ...

In a report released today, Jason Gerberry from Bank of America Securities maintained a Buy rating on Royalty Pharma (RPRX – Research Report), ...

There’s an old adage in baseball that says, “Pay players before they get good.” And through the first three weeks of the 2025 MLB season, we’ve seen several teams secure young members of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lyons was joined by his high school teammate and current USC offensive line commit, Vlad Dyakonov, as the Trojans continue building momentum with one of the most talented duos on the West Coast.

Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 45th Annual Health Care Conference on March 4, 2025 at 2:30 p.m. ET. The webcast will ...

Vlad Miriță și soția lui, Maria Natură, au peste nouă ani de căsnicie și au dezvăluit detalii despre relația lor. Cei doi au un băiețel de șase ani, pe care îl adoră și sunt fericiți de familia pe ...

Medicul neurochirurg Vlad Ciurea atrage atenția asupra acestui aspect și le recomandă românilor cumpătare. El subliniază că pasca și cozonacul ar trebui consumate la momentul potrivit al zilei, pentru ...